Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prasad Rao Gundugurti

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Indian Journal of Psychological Medicine|December 5, 2017
A Cross-sectional Study to Estimate Cardiovascular Risk Factors in Patients with Bipolar DisorderSwetha Reddy Damegunta, Prasad Rao Gundugurti
Indian Journal of Psychological Medicine|February 5, 2025
Mindfulness: Impact and Place in Physician's Well-beingViswanath Bandi, Prasad Rao Gundugurti
Indian Journal of Psychiatry|May 23, 2022
Management of Psychiatric Disorders in Patients with Cardiovascular DiseasesPrasad Rao Gundugurti, Ranjan Bhattacharyya, Amulya Koneru
Indian Journal of Psychiatry|May 23, 2022
Ethics and LawPrasad Rao Gundugurti, Ranjan Bhattacharyya, Sandeep Kondepi, et al.
Asian Journal of Psychiatry|August 27, 2017
Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in IndiaPrasad Rao Gundugurti, Rajesh Nagpal, Ashit Sheth, et al.
Asian Journal of Psychiatry|May 26, 2024
Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trialPrasad Rao Gundugurti, Nagaraju Banda, Siva Sankara Rao Yadlapalli, et al.
Medical Cannabis and Cannabinoids|January 30, 2026
A Randomized, Single-Dose, Single-Sequence, Two-Arm (Fasting and Fed), Open-Label Study on the Oral Pharmacokinetics of a Nanodispersible Cannabidiol Solution (150 mg/mL)Prasad Rao Gundugurti, Monila Nadikudi, Ramyasree Thatikonda, et al.
JAMA Psychiatry|July 4, 2019
Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association StudySathish Periyasamy, Sujit John, Raman Padmavati, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Indian Journal of Psychological Medicine|December 5, 2017
A Cross-sectional Study to Estimate Cardiovascular Risk Factors in Patients with Bipolar DisorderSwetha Reddy Damegunta, Prasad Rao Gundugurti
Indian Journal of Psychological Medicine|February 5, 2025
Mindfulness: Impact and Place in Physician's Well-beingViswanath Bandi, Prasad Rao Gundugurti
Indian Journal of Psychiatry|May 23, 2022
Management of Psychiatric Disorders in Patients with Cardiovascular DiseasesPrasad Rao Gundugurti, Ranjan Bhattacharyya, Amulya Koneru
Indian Journal of Psychiatry|May 23, 2022
Ethics and LawPrasad Rao Gundugurti, Ranjan Bhattacharyya, Sandeep Kondepi, et al.
Asian Journal of Psychiatry|August 27, 2017
Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in IndiaPrasad Rao Gundugurti, Rajesh Nagpal, Ashit Sheth, et al.
Asian Journal of Psychiatry|May 26, 2024
Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trialPrasad Rao Gundugurti, Nagaraju Banda, Siva Sankara Rao Yadlapalli, et al.
Medical Cannabis and Cannabinoids|January 30, 2026
A Randomized, Single-Dose, Single-Sequence, Two-Arm (Fasting and Fed), Open-Label Study on the Oral Pharmacokinetics of a Nanodispersible Cannabidiol Solution (150 mg/mL)Prasad Rao Gundugurti, Monila Nadikudi, Ramyasree Thatikonda, et al.
JAMA Psychiatry|July 4, 2019
Association of Schizophrenia Risk With Disordered Niacin Metabolism in an Indian Genome-wide Association StudySathish Periyasamy, Sujit John, Raman Padmavati, et al.
Pageof 1